Why retinoic acid is effective in this setting but not against primary tumors, has been speculated about for nearly 50 years. Scientists resolved the mystery, showing the drug 'hijacks' a normal developmental pathway to trigger cancer cell death.
Read more https://www.sciencedaily.com/releases/2025/02/250228133028.htm